Non‐Classical Swine Leukocyte Antigens SLA‐6, ‐7, and ‐8, Are Xenoantigens for Some Waitlisted Patients
Xenotransplantation · 2024-05 · 31 (3)
DOI: 10.1111/xen.12872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 23.06.2024. Verfasst von Luz Reyes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Miami School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Antigens, Heterophile, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Attack of donor tissues by pre‐formed anti‐pig antibodies is well known to cause graft failure in xenotransplantation. Genetic engineering of porcine donors to eliminate targets of these pre‐formed antibodies coupled with advances in immunosuppressive medicines have now made it possible to achieve extended survival in the pre‐clinical pig‐to‐non‐human primate model. Despite these improvements, antibodies remain a risk over the lifetime of the transplant, and many patients continue to have pre‐formed donor‐specific antibodies even to highly engineered pigs. While therapeutics exist that can help mitigate the detrimental effects of antibodies, they act broadly potentially dampening beneficial immunity. Identifying additional xenoantigens may enable more targeted approaches, such as gene editing, to overcome these challenges by further eliminating antibody targets on donor tissue. Because we have found that classical class I swine leukocyte antigens are targets of human antibodies, we now examine whether related pig proteins may also be targeted by human antibodies. We show here that non‐classical class I swine leukocyte proteins (SLA‐6, ‐7, ‐8) can be expressed at the surface of mammalian cells and act as antibody targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of Miami School of Medicine, Miami, Florida, USA.
- Gift of Hope Organ and Tissue Donor Network, Itasca, Illinois, USA.
- Makana Therapeutics, Miami, Florida, USA.
ORCID-Profile: Christopher Burlak, Matt Tector, Alfred Joseph Tector
Förderung
- NIH HHS
- NIAID NIH HHS
- NCI NIH HHS
- National Cancer Institute of the National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Reyes, L., Wang, Z. Y., Estrada, J., Burlak, C., Gennuso, V. N., Ho, S., Tector, M., & Tector, A. J. (2024). Non‐Classical Swine Leukocyte Antigens SLA‐6, ‐7, and ‐8, Are Xenoantigens for Some Waitlisted Patients. Xenotransplantation, 31(3). https://doi.org/10.1111/xen.12872
Vancouver
Reyes L, Wang ZY, Estrada J, Burlak C, Gennuso VN, Ho S, et al. Non‐Classical Swine Leukocyte Antigens SLA‐6, ‐7, and ‐8, Are Xenoantigens for Some Waitlisted Patients. Xenotransplantation. 2024;31(3). doi:10.1111/xen.12872
BibTeX
@article{Reyes2024,
author = {Reyes, Luz and Wang, Zheng-Yu and Estrada, Jose and Burlak, Christopher and Gennuso, Victor Novara and Ho, Sam and Tector, Matt and Tector, Alfred Joseph},
title = {Non‐Classical Swine Leukocyte Antigens SLA‐6, ‐7, and ‐8, Are Xenoantigens for Some Waitlisted Patients},
journal = {Xenotransplantation},
year = {2024},
volume = {31},
number = {3},
doi = {10.1111/xen.12872}
}
EUVIMED